Allogene Therapeutics, Inc. (ALLO) Q3 2024 Earnings Call Transcript Summary
Allogene Therapeutics, Inc. (ALLO) Q3 2024 Earnings Call Transcript Summary
Allogene Therapeutics, Inc. (ALLO) 2024年第三季度業績會議電話摘要
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.The following is a summary of the Allogene Therapeutics, Inc. (ALLO) Q3 2024 Earnings Call Transcript:
以下是Allogene Therapeutics, Inc. (ALLO) 2024年第三季度業績會議文本摘要:
Financial Performance:
財務表現:
Allogene reported their financial results for the third quarter of 2024, as detailed in a press release.
Allogene公佈了他們2024年第三季度的財務結果，詳細內容見新聞稿。
Business Progress:
業務進展:
Allogene is making advancements in clinical trials, regulatory filings, and manufacturing capabilities.
Allogene在臨床試驗、監管申報和製造能力方面正取得進展。
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：如需更全面的詳情，請參閱投資人關係網站。本文僅供投資者參考，不作任何指引或建議。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間